Oral contraceptive pills provide long-term protection against endometrial cancer in women with PCOS, with an estimated relative risk reduction of about 50% after 4 years of use and 70% after 12 years, and that protection persists at roughly 50% even more than 20 years after stopping, according to a clinical review in PMC. That matters because PCOS often brings irregular bleeding, acne, hirsutism, and prolonged exposure to unopposed oestrogen.

Birth control pills can prevent pregnancy and treat core PCOS symptoms at the same time. In UK practice, they're used mainly to regulate cycles and lower androgen-driven symptoms such as acne and excess hair growth. If you're comparing the best birth control pills for PCOS, the useful question isn't which pill is “strongest”. It's which formulation best fits your dominant symptom pattern, metabolic profile, and risk factors. If you're also weighing insulin-focused treatment, Venus Health Co. on metformin for PCOS offers a complementary view of where metformin fits.

Table of Contents

• 1. Combined Oral Contraceptives with Cyproterone Acetate
  • When CPA makes clinical sense
  • Practical cautions
• 2. Combined Oral Contraceptives with Drospirenone
  • Why drospirenone stands out
  • Prescription considerations
• 3. Combined Oral Contraceptives with Norgestimate
  • Where norgestimate fits
  • How to frame the choice
• 4. Low-Dose Combined Oral Contraceptives 20 micrograms Ethinylestradiol
  • Who benefits most from low-dose EE
  • What to discuss with a clinician
• 5. Progestin-Only Pills Desogestrel 75 micrograms
  • Where desogestrel helps
  • Best use case
• 6. Norethisterone Extended-Cycle Formulation for PCOS
  • Why an extended cycle can work
  • Limits and trade-offs
• 7. Spironolactone Anti-Androgen as Adjunctive Therapy in PCOS
  • When combined pills alone aren't enough
  • Real-world role
• 7-Option Comparison: Birth Control for PCOS
• Your Next Steps with a Clinician

1. Combined Oral Contraceptives with Cyproterone Acetate

Cyproterone acetate combinations sit in a very specific place in PCOS prescribing. They're not the default choice for most patients. The current international PCOS guidance used in UK practice places combined oral contraceptives first-line overall, but reserves the pill containing 35 µg ethinylestradiol with cyproterone acetate as a second-line option for women with moderate to severe hirsutism or acne because of its higher adverse-effect burden, including arterial thrombosis, as summarised in GREM Journal's review of the 2023 International PCOS Guideline.

That distinction is easy to miss. CPA pills can look attractive because they target androgen symptoms directly, but they're usually better framed as a targeted escalation rather than a routine starting point.

When CPA makes clinical sense

A real-world example is the patient whose main complaint isn't missed periods but visible androgen symptoms: persistent jawline acne, worsening facial hair, or scalp hair thinning. In that setting, a clinician may favour a more anti-androgenic formulation if lower-risk options haven't given enough benefit.

Practical rule: CPA pills are usually strongest on symptom logic when hyperandrogenism is the main problem and safer first-line combined pills haven't done enough.

The prescription conversation should stay broader than skin and hair. Diet, exercise, blood pressure review, and metabolic follow-up still matter, especially because PCOS rarely presents as a skin-only condition. Patients who are also exploring weight-focused therapy often need a joined-up plan for both symptom control and metabolic risk, which is why many are also reading about GLP-1 medicines and PCOS management.

Practical cautions

• Use specialist judgement: CPA combinations are generally better viewed as second-line rather than routine first-line prescribing.
• Watch for vascular warning signs: New leg swelling, chest pain, or severe headaches need urgent medical advice.
• Review whether the benefit justifies the risk: If acne or hirsutism improve but side effects build, the balance may shift quickly.

For the best birth control pills for PCOS, CPA formulations are often the right answer for a narrower subgroup than online rankings imply.

2. Combined Oral Contraceptives with Drospirenone

Drospirenone is often the most persuasive starting point when androgen symptoms and metabolic caution both matter. UK clinical reviews describe drospirenone, dienogest, and nomegestrol-containing options as preferable for managing hyperandrogenism, and specifically note drospirenone as a preferred progestin because of anti-androgenic effects on acne, hirsutism, and androgenic alopecia in Sova Care's UK-focused PCOS review.

That makes drospirenone-based pills one of the clearest “fit” options for the patient who wants cycle control but is equally worried about skin, hair, and fluid retention. In practice, this is why Yasmin-like or similar DRSP-containing formulations often stay near the top of clinician shortlists.

Why drospirenone stands out

Drospirenone's profile matters because PCOS treatment isn't only about forcing predictable bleeding. It's about choosing a progestin that doesn't work against the symptom pattern you're trying to control. Compared with older progestins, DRSP is better aligned with patients whose main quality-of-life issues are cosmetic androgen symptoms.

A typical scenario is a woman with irregular cycles and adult acne who also feels bloated on some pills. A drospirenone pill may suit that pattern better than an older, less anti-androgenic formulation.

Some pills regulate bleeding. Drospirenone-based pills often do that while also matching the biology of androgen excess more closely.

Prescription considerations

• Check interacting medicines: Potassium-sparing medicines and some analgesic patterns may need review before starting.
• Give it time: Skin and hair changes usually lag behind cycle changes in day-to-day clinical experience.
• Assess the whole profile: Blood pressure, migraine history, smoking status, and clotting risk still matter more than brand preference.

Among the best birth control pills for PCOS, drospirenone combinations often represent the most balanced compromise between androgen control and practical long-term use.

3. Combined Oral Contraceptives with Norgestimate

Norgestimate rarely gets the same attention as drospirenone or CPA, but it often deserves a place in evidence-based prescribing conversations. The key reason is restraint. For some patients, the best pill isn't the most anti-androgenic one. It's the one that controls cycles without adding unnecessary metabolic concern or tolerability problems.

The broader guideline position supports that thinking. Expert consensus notes there's no definitive evidence showing one combined oral contraceptive formulation is superior to another for cycle regulation or androgen reduction overall, while combined pills remain the most commonly prescribed long-term medication for women with PCOS who aren't trying to conceive, as discussed in the Journal of Clinical Endocrinology & Metabolism review.

Where norgestimate fits

That “no clear winner” point changes how to think about norgestimate. It means a moderate, well-tolerated formulation can be a rational choice, especially when the patient's symptoms are mixed rather than extreme. If acne is present but not severe, and the bigger picture includes lipid concerns, weight concerns, or sensitivity to side effects, norgestimate can be a sensible middle ground.

A practical example is the patient returning to contraception after a difficult experience on a more anti-androgenic pill. She still needs cycle control and some androgen benefit, but not at any cost. That's where a norgestimate option may be clinically attractive.

How to frame the choice

• Think in trade-offs: Stronger anti-androgen activity isn't automatically better if tolerability suffers.
• Use symptom hierarchy: Mild acne plus irregular cycles may justify a more moderate combined pill.
• Leave room to step up later: If cycle control improves but hair or acne don't, the next prescription decision becomes clearer.

For readers searching best birth control pills for PCOS, norgestimate is often a reliably effective option rather than the obvious one. It fits patients who need steadier long-term management more than aggressive symptom suppression.

4. Low-Dose Combined Oral Contraceptives 20 micrograms Ethinylestradiol

If one prescribing principle now dominates UK PCOS care, it's this: use the lowest effective oestrogen dose. Current guidance recommends 20 to 30 µg of ethinylestradiol or equivalent to balance contraceptive efficacy with metabolic and cardiovascular safety, and evidence reviewed in PMC on contraception in PCOS reports that pills containing 20 µg EE carry a venous thromboembolism relative risk between 0.9 and 1.7, while 30 to 40 µg EE is associated with an arterial thrombosis risk increased by 1.3- to 2.3-fold.

That's one of the clearest risk-based distinctions in this whole category. It doesn't prove a 20 µg pill is the best choice for every woman, but it strongly explains why lower-dose combined pills have become standard thinking for many patients with PCOS.

Who benefits most from low-dose EE

A common scenario is the woman with PCOS who wants symptom control but also has added cardiovascular concern, such as higher body weight or a family history that pushes prescribers toward caution. In those cases, low-dose EE formulations often offer enough hormonal effect without reaching for more oestrogen than necessary.

Breakthrough bleeding can be the trade-off. That doesn't always mean the pill is “too weak”. Sometimes it means the body needs time, or that the formulation is safe but not the best personal fit.

Lower-dose EE pills often make the most sense when risk reduction is part of the prescribing goal, not an afterthought.

What to discuss with a clinician

• Bleeding pattern versus risk profile: Lighter hormone exposure may come with more early spotting.
• Daily consistency: Lower-dose formulations leave less room for missed pills.
• Whether the progestin complements the oestrogen dose: The oestrogen number matters, but so does the progestin paired with it.

In any shortlist of the best birth control pills for PCOS, low-dose combined pills deserve high placement because they reflect where modern guideline logic has moved.

5. Progestin-Only Pills Desogestrel 75 micrograms

Progestin-only pills are often underused in PCOS discussions because they don't look as glamorous on acne and hirsutism as anti-androgenic combined pills. But that misses their real role. They're often the right answer when oestrogen is a poor fit or clearly contraindicated.

This matters in everyday practice for patients with migraine with aura, a history that raises clot concern, or other reasons to avoid combined hormonal contraception. For those patients, the “best” pill isn't the one with the broadest symptom reach. It's the one they can use safely and consistently.

Where desogestrel helps

Desogestrel 75 micrograms is often considered when reliable contraception is needed but combined pills aren't suitable. In PCOS, it may help some patients by suppressing ovulation and altering bleeding patterns, though it generally won't match combined pills for androgen-focused symptom control.

That's why clinicians often pair expectations carefully. A patient whose top priority is avoiding pregnancy and staying off oestrogen may do well on desogestrel. A patient whose main complaint is severe acne may need a different strategy, or an adjunctive dermatology plan. Readers also trying to address weight and insulin-related issues often end up exploring broader support such as PCOS weight-loss treatment pathways.

Best use case

• Prioritise safety when oestrogen isn't suitable: That's the strongest reason to consider a POP.
• Prepare for irregular bleeding: Bleeding can be less predictable than with a combined pill.
• Don't expect major anti-androgen benefit on its own: Some patients need separate treatment for skin or hair symptoms.

For best birth control pills for PCOS, desogestrel belongs on the list because safety-based prescribing is still good prescribing.

6. Norethisterone Extended-Cycle Formulation for PCOS

Extended-cycle norethisterone-containing regimens are less about anti-androgen elegance and more about practical cycle control. They can appeal to patients who are exhausted by frequent withdrawal bleeds, menstrual-related disruption, or the cognitive burden of repeated monthly cycling.

In PCOS, that can matter more than many comparisons suggest. Some women don't chiefly want a “skin pill” or a “weight-neutral pill”. They want fewer bleeding episodes and simpler routine control.

Why an extended cycle can work

The clinical logic is straightforward. Fewer scheduled hormone-free intervals can reduce bleeding frequency and make treatment feel less intrusive. For the patient with irregular cycles plus painful, disruptive bleeding episodes, that can be a meaningful prescription goal even if another formulation might look more fashionable online.

A realistic example is the patient balancing work, childcare, and PCOS symptoms who doesn't want thirteen separate reminders each year that her cycle is difficult to manage. Extended-cycle prescribing can reduce that constant churn.

For some patients, convenience is a clinical outcome. Better adherence often starts with a regimen that feels easier to live with.

Limits and trade-offs

• Norethisterone isn't the most anti-androgenic choice: If acne or hirsutism dominate, another pill may fit better.
• Breakthrough bleeding can still happen early on: That can improve with time and careful review.
• Adherence still matters: Extended-cycle doesn't mean low-maintenance if daily dosing slips.

This option belongs in a serious list of the best birth control pills for PCOS because practical adherence is often what determines whether a theoretically good pill becomes a useful one.

7. Spironolactone Anti-Androgen as Adjunctive Therapy in PCOS

Strictly speaking, spironolactone isn't a birth control pill. It still belongs in this conversation because it often changes the answer to a more useful clinical question: not “Which pill is best?” but “Which pill plus adjunctive therapy best matches the patient's symptoms?”

For women whose cycles improve on a combined pill but whose acne, hirsutism, or scalp hair loss remain stubborn, spironolactone is commonly considered as an add-on anti-androgen. That's where prescription care moves beyond contraception and into layered endocrine management.

A short clinical explainer can help frame that role:

When combined pills alone aren't enough

One important guideline-backed point sharpens this decision. For irregular cycles and hirsutism, combined oral contraceptive pills are recommended first-line, and metformin is significantly inferior for cycle regularity with an odds ratio of 0.17 and 95% CI 0.05 to 0.57 compared with COCPs, according to the 2023 PCOS guideline update in JCEM. That means if the main issue is cycle regularity plus androgen symptoms, clinicians often start with a COCP and only then consider add-ons like spironolactone when cosmetic symptoms persist.

That sequencing matters. It stops patients from expecting a metabolic medicine to solve a primarily androgenic problem.

Real-world role

• Use spironolactone as an adjunct, not a replacement: It commonly complements a combined pill rather than substitutes for one.
• Monitor carefully: Potassium and renal function oversight matter in routine prescribing.
• Set expectations: Hair and skin changes usually take longer than bleeding-pattern changes.

Patients who are also targeting weight reduction sometimes need a coordinated discussion about contraception, anti-androgen therapy, and medically supervised fat-loss treatment, including PCOS medicines used in weight-loss pathways. For women managing facial hair, non-pill approaches can also matter, including laser and electrolysis options for PCOS-related hair removal.

7-Option Comparison: Birth Control for PCOS

Your Next Steps with a Clinician

PCOS affects a large share of women of reproductive age, yet prescribing decisions still depend less on rankings than on matching the formulation to the clinical problem in front of you. Current international guidance places combined oral contraceptives as first-line treatment for menstrual irregularity and hyperandrogenic symptoms in adults with PCOS who do not want pregnancy, while also noting that no single combined pill is consistently superior across every endpoint. In practice, that shifts the consultation away from "best pill" lists and toward a narrower question: which option offers the best trade-off between androgen control, bleeding profile, metabolic tolerability, and contraceptive safety for you.

That trade-off should be explicit.

If acne, hirsutism, or scalp hair thinning is the main priority, the strongest discussion usually centres on anti-androgenic options and the time course of response. Drospirenone-containing pills often make sense when skin symptoms matter and thrombotic risk is not increased. Cyproterone acetate combinations may be considered when hyperandrogenism is more severe, but they usually warrant a more cautious risk-benefit discussion because efficacy is only one part of the prescribing decision. If blood pressure, migraine history, smoking status, or cardiometabolic risk raises concern, lower-dose ethinylestradiol options or an oestrogen-free approach may be more appropriate, even if the cosmetic benefit is less pronounced.

The same logic applies to metabolic planning. PCOS management works better when contraception, weight strategy, insulin resistance, and monitoring are handled as one treatment plan rather than separate tasks. Even modest weight loss can improve cycle regularity and ovulatory function in many patients, which is why clinicians often pair pill selection with advice on nutrition, exercise, and metabolic follow-up instead of treating hormonal symptoms in isolation.

There is also a practical prescribing question that deserves direct discussion if you are using, or considering, a GLP-1 medicine for weight management. LloydsPharmacy Online Doctor's PCOS guidance reflects the broader UK information gap here. Patient guidance discusses weight loss and contraceptive choices, but real-world counselling is still catching up on how gastrointestinal side effects, adherence, and concurrent treatment goals may affect pill use in women managing both PCOS and obesity.

A useful appointment is specific. Ask your clinician to compare options against four points: your main symptom target, your VTE and cardiovascular risk factors, your metabolic profile, and how likely you are to take the pill consistently. If hirsutism is driving treatment, ask how long the chosen pill should be given before judging response and whether spironolactone should be added later. If cycle control matters more than skin outcomes, ask whether a lower-dose combined pill or extended-cycle regimen would meet that goal with fewer trade-offs.

Schedule a review with a clinician, in person or through Trim's 5-minute digital check, and go in with clear priorities: the symptom you most want to improve, the side effect you most want to avoid, the medicines you already take, and whether weight reduction is part of your current plan.

Trim offers a UK-based route to medically supervised weight management for adults who want a joined-up plan rather than fragmented advice. Through Trim, you can complete a quick digital consultation for clinician review, discuss prescription options including GLP-1 treatments where appropriate, and build a plan that fits alongside PCOS care, nutrition, exercise, and longer-term metabolic goals.